Yanda International Hospital
Crohn's disease treatment cost in China typically includes essential diagnostics like gastroscopy with biopsy, which ranges from $100 to $300, and biochemical blood analysis from $100 to $100. Primary medical interventions such as hormone therapy cost $3,500 to $9,800. Total expenses depend on the need for biologics, surgical stays, and outpatient maintenance requirements. Patients can expect 30-50% savings compared to the US. Top cities for this treatment include Beijing and Shanghai.
Typical Crohn's Disease Treatment Costs in China
Bookimed Expert Insight: Early tumor screening and accurate staging are best managed by specialized gastroenterologists. Dr. Sun Guanxi in Shanghai brings experience from thousands of endoscopic procedures for precise diagnosis. For complex cases requiring inpatient care, Yanda International Hospital in Beijing offers Joint Commission International (JCI) accredited Class A level III facilities. This high-tier clinical environment is ideal for international patients seeking western-standard hospital safety and multidisciplinary care.
| Chiny | Turcja | Austria | |
| Resekcja pęcherzyka żółciowego | od $7,500 | od $2,900 | od $9,000 |
| Leczenie komórkami macierzystymi | od $11,500 | od $4,675 | od $8,500 |
| Hormonterapia | od $3,500 | od $407 | od $7,000 |
Państwo nie płacą za usługi Bookimed. Ceny leczenia choroby leśniowskiego-crohna odpowiadają cennikowi kliniki. Płatność dokonywana jest bezpośrednio w klinice po przyjeździe. Dostępna jest płatność w ratach.
Bookimed dba o Państwa bezpieczeństwo. Współpracujemy tylko z klinikami spełniającymi wysokie międzynarodowe standardy w leczeniu choroby Leśniowskiego-Crohna. Posiadają one wymagane licencje do obsługi pacjentów międzynarodowych na całym świecie.
Bookimed oferuje bezpłatną pomoc i wsparcie. Osobisty koordynator medyczny pozostaje w kontakcie przed, w trakcie i po podróży. Nie będą Państwo sami w innym kraju podczas leczenia choroby Leśniowskiego-Crohna.
Top Chinese hospitals for Crohn’s disease treatment include Peking Union Medical College Hospital and Yanda International Hospital. These JCI-accredited facilities use multidisciplinary teams and advanced biologics. Many centers integrate Western medicine with traditional protocols. Specialized inflammatory bowel disease units manage complex cases across Beijing, Shanghai, and Guangzhou.
Bookimed Expert Insight: Yanda International Hospital stands out by combining international JCI standards with traditional Chinese medicine for chronic inflammation. While many national centers focus strictly on Western protocols, this integrated approach serves over 2,500,000 patients annually. The clinic is particularly accessible for international patients, offering dedicated services for Arabic and Russian speakers.
Patient Consensus: Patients recommend focusing on top-tier hospitals in Beijing or Shanghai but warn about long wait times. Many advise using hospital apps to book appointments months in advance and bringing translated records.
Infliximab and Adalimumab are widely available and approved for treating moderate to severe Crohn’s disease in China. These biological drugs are included in the National Reimbursement Drug List. Patients can access the original brands or several local biosimilars at accredited medical facilities.
Bookimed Expert Insight: While many think only specialized oncology centers carry high-end medications, JCI-accredited facilities like Yanda International Hospital manage massive patient volumes reaching 2,500,000 annually. This scale often ensures a steady supply of complex biologics that smaller regional clinics may lack.
Patient Consensus: Patients note that getting approved for biologics can take 2 to 3 months for screenings. They recommend joining WeChat groups to find hospitals with current stock and English-speaking staff.
China integrates Traditional Chinese Medicine (TCM) as an adjuvant therapy alongside Western protocols. This dual approach combines biologics with specialized herbal decoctions and acupuncture. These therapies aim to regulate the brain-gut axis and improve local intestinal mucosal healing in patients.
Bookimed Expert Insight: Patient volume impacts integration quality significantly in China. Yanda International Hospital serves 2,500,000 patients every year. High-volume centers often possess more clinical experience in combining herbal decoctions with modern hormone therapies safely. Choosing JCI-accredited Class A level III facilities ensures standardized TCM formulas that meet rigorous safety criteria.
Patient Consensus: Patients note that combining standard biologics with hospital-vetted herbs leads to the best results. Many emphasize that following a doctor-led integrated protocol is safer than using standalone or unregulated herbal treatments.
Chinese clinics focus on stabilizing the spleen and stomach through a combined approach. Doctors emphasize warm, cooked foods like congee and bone broths to reduce internal inflammation. Patients often receive exclusive enteral nutrition (EEN) via liquid formulas to induce clinical remission during active phases.
Bookimed Expert Insight: Quality signals in China prioritize clinic classification over individual department size. Leading centers like Yanda International Hospital are designated as Class A Level III. This represents the high tier of Chinese healthcare complexity and technology. Patients should prioritize these JCI-accredited facilities when seeking integrated Western and Traditional Chinese Medicine (TCM) protocols.
Patient Consensus: Patients note that diets often include functional ingredients like goji berries and dates. Many find that shifting to warm, cooked meals provides more relief than standard Western bland diets.